Predictors of latent tuberculosis infection treatment completion in the US private sector: an analysis of administrative claims data

Details

• Alternative Title:
  BMC Public Health
• Personal Author:
  Stockbridge, Erica L. ; Miller, Thaddeus L. ; Carlson, Erin K. ; Ho, Christine
• Description:
  Background ; Factors that affect latent tuberculosis infection (LTBI) treatment completion in the US have not been well studied beyond public health settings. This gap was highlighted by recent health insurance-related regulatory changes that are likely to increase LTBI treatment by private sector healthcare providers. We analyzed LTBI treatment completion in the private healthcare setting to facilitate planning around this important opportunity for tuberculosis (TB) control in the US. ; Methods ; We analyzed a national sample of commercial insurance medical and pharmacy claims data for people ages 0 to 64 years who initiated daily dose isoniazid treatment between July 2011 and March 2014 and who had complete data. All individuals resided in the US. Factors associated with treatment completion were examined using multivariable generalized ordered logit models and bivariate Kruskal-Wallis tests or Spearman correlations. ; Results ; We identified 1072 individuals with complete data who initiated isoniazid LTBI treatment. Treatment completion was significantly associated with less restrictive health insurance, age < 15 years, patient location, use of interferon-gamma release assays, non-poverty, HIV diagnosis, immunosuppressive drug therapy, and higher cumulative counts of clinical risk factors. ; Conclusions ; Private sector healthcare claims data provide insights into LTBI treatment completion patterns and patient/provider behaviors. Such information is critical to understanding the opportunities and limitations of private healthcare in the US to support treatment completion as this sector’s role in protecting against and eliminating TB grows. ; Electronic supplementary material ; The online version of this article (10.1186/s12889-018-5578-3) contains supplementary material, which is available to authorized users.
• Subjects:
  • Research Article
  • Latent tuberculosis infection
  • LTBI
  • Treatment completion
  • Claims data
  • Administrative data
  • Isoniazid
  • Epidemiology
  • Health service delivery
  • Public health practice
  More +
• Source:
  BMC Public Health. 18.
• Pubmed ID:
  29843664
• Pubmed Central ID:
  PMC5975486
• Document Type:
  Journal Article
• Volume:
  18
• Download URL:
  https://stacks.cdc.gov/view/cdc/56522/cdc_56522_DS1.pdf
• File Type:
  [PDF - 898.76 KB]
• Collection(s):
  CDC Public Access
• Main Document Checksum:
  urn:sha-512:8544f5699e8e66d8ce5eff6b2b7c7cd02596fbd65274761baac8f66a0dd65a220dbcb1f5cc15bea11eb8c94741fc4a40a5cf3179fae0385440ac82bf12e814ba